StagingMastodyniaOvarianSuppressionCyclophosphamideFlowCytometryAntiemeticCalcificationsAromataseInhibitorsEGFR(epidermalgrowth factorreceptor)PagetDiseaseDimplingPaclitaxelTripleNegativeBreastCancerCheckpointInhibitorDocetaxelDoseDenseTherapyPARPInhibitorsDown-StagingCo-survivorCytostaticBevacizumabFISHGuaranteedRenewableInsuranceEstrogenDoxorubicinNodeNegativePI3KinaseInhibitors5-FluorouracilExcisionalBiopsyAnastrozoleTyrosine-KinaseInhibitorCapecitabineBRCAGeneSelf-examinationLapatinibGenomicTestingMultifocalTumorsPalbociclibDefinitiveSurgeryMethotrexateAngiogenesisKi-67RateBreastTomosynthesisRaloxifeneProgestinHerceptinHormoneReceptorStatusGeneticCounselingAyurvedaAxillarySamplingER+ECOGScoreWomen ages40+ shouldhave a clinicalbreast examat least yearlyAntibodyTherapyGailModelHER-2MRI1 in 8womenBilateralProphylacticMastectomyRadiotherapyMastectomyWomen ages20-39 yoshould have aclinical breastexam at leastevery 3 years.Alcohol intakeof more thantwo drinks perday is a riskfactor for breastcancerEstimated 2,150 menwill be diagnosedwith breast cancerand approximately410 will die each yearEstradiolLumpectomyApoptosisNeoadjuvantTherapyLumpPathologicResponseLymphoscintigraphyChemotherapyGeneticPredispositionIn-situCarcinomaNodePositiveMammography is alow-dose X-rayexamination thatcan detect breastcancer two yearsbefore it is largeenough to be feltFamilyHistoryMegestrolAcetateAfrican-Americanwomen have a lowerchance of breastcancer overall, butthey are 40% morelikely to die frombreast cancer thanwhite womenAdjuvantTherapyGeneMutationMetastasisHormoneReplacementTherapyTumorGradeBI-RADSTriplePositiveBreastCancerChemopreventionNeoplasmFibroadenomaBOCABreastCancerCAMMorpheaAbsoluteRiskTamoxifenPhyllodesTumorBreast cancer isthe leading causeof death in womenbetween the agesof 40 and 55RADLymphNodeStatusInvasiveBreastCancerCystmTORInhibitorsGermlineMutationSERMPrecisionMedicinePhysicalactivity mayreduce therisk of breastcancersBiopsyAdenocarcinomaOligometastasesCachexiaCDK4/6InhibitorsMultimodalityTherapyAdvocacyAlopeciaBrachytherapyIntraductalPapillomaCytotoxicER-LCISRelapsePalpationACChemotherapyCMFChemotherapyKappaEpsilonImmunotherapyFor every 1,000screeningmammogramsperformed, aboutfive breast cancersare detected.StagingMastodyniaOvarianSuppressionCyclophosphamideFlowCytometryAntiemeticCalcificationsAromataseInhibitorsEGFR(epidermalgrowth factorreceptor)PagetDiseaseDimplingPaclitaxelTripleNegativeBreastCancerCheckpointInhibitorDocetaxelDoseDenseTherapyPARPInhibitorsDown-StagingCo-survivorCytostaticBevacizumabFISHGuaranteedRenewableInsuranceEstrogenDoxorubicinNodeNegativePI3KinaseInhibitors5-FluorouracilExcisionalBiopsyAnastrozoleTyrosine-KinaseInhibitorCapecitabineBRCAGeneSelf-examinationLapatinibGenomicTestingMultifocalTumorsPalbociclibDefinitiveSurgeryMethotrexateAngiogenesisKi-67RateBreastTomosynthesisRaloxifeneProgestinHerceptinHormoneReceptorStatusGeneticCounselingAyurvedaAxillarySamplingER+ECOGScoreWomen ages40+ shouldhave a clinicalbreast examat least yearlyAntibodyTherapyGailModelHER-2MRI1 in 8womenBilateralProphylacticMastectomyRadiotherapyMastectomyWomen ages20-39 yoshould have aclinical breastexam at leastevery 3 years.Alcohol intakeof more thantwo drinks perday is a riskfactor for breastcancerEstimated 2,150 menwill be diagnosedwith breast cancerand approximately410 will die each yearEstradiolLumpectomyApoptosisNeoadjuvantTherapyLumpPathologicResponseLymphoscintigraphyChemotherapyGeneticPredispositionIn-situCarcinomaNodePositiveMammography is alow-dose X-rayexamination thatcan detect breastcancer two yearsbefore it is largeenough to be feltFamilyHistoryMegestrolAcetateAfrican-Americanwomen have a lowerchance of breastcancer overall, butthey are 40% morelikely to die frombreast cancer thanwhite womenAdjuvantTherapyGeneMutationMetastasisHormoneReplacementTherapyTumorGradeBI-RADSTriplePositiveBreastCancerChemopreventionNeoplasmFibroadenomaBOCABreastCancerCAMMorpheaAbsoluteRiskTamoxifenPhyllodesTumorBreast cancer isthe leading causeof death in womenbetween the agesof 40 and 55RADLymphNodeStatusInvasiveBreastCancerCystmTORInhibitorsGermlineMutationSERMPrecisionMedicinePhysicalactivity mayreduce therisk of breastcancersBiopsyAdenocarcinomaOligometastasesCachexiaCDK4/6InhibitorsMultimodalityTherapyAdvocacyAlopeciaBrachytherapyIntraductalPapillomaCytotoxicER-LCISRelapsePalpationACChemotherapyCMFChemotherapyKappaEpsilonImmunotherapyFor every 1,000screeningmammogramsperformed, aboutfive breast cancersare detected.

BOCA Bingo - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
  1. Staging
  2. Mastodynia
  3. Ovarian Suppression
  4. Cyclophosphamide
  5. Flow Cytometry
  6. Antiemetic
  7. Calcifications
  8. Aromatase Inhibitors
  9. EGFR (epidermal growth factor receptor)
  10. Paget Disease
  11. Dimpling
  12. Paclitaxel
  13. Triple Negative Breast Cancer
  14. Checkpoint Inhibitor
  15. Docetaxel
  16. Dose Dense Therapy
  17. PARP Inhibitors
  18. Down-Staging
  19. Co-survivor
  20. Cytostatic
  21. Bevacizumab
  22. FISH
  23. Guaranteed Renewable Insurance
  24. Estrogen
  25. Doxorubicin
  26. Node Negative
  27. PI3 Kinase Inhibitors
  28. 5-Fluorouracil
  29. Excisional Biopsy
  30. Anastrozole
  31. Tyrosine-Kinase Inhibitor
  32. Capecitabine
  33. BRCA Gene
  34. Self-examination
  35. Lapatinib
  36. Genomic Testing
  37. Multifocal Tumors
  38. Palbociclib
  39. Definitive Surgery
  40. Methotrexate
  41. Angiogenesis
  42. Ki-67 Rate
  43. Breast Tomosynthesis
  44. Raloxifene
  45. Progestin
  46. Herceptin
  47. Hormone Receptor Status
  48. Genetic Counseling
  49. Ayurveda
  50. Axillary Sampling
  51. ER+
  52. ECOG Score
  53. Women ages 40+ should have a clinical breast exam at least yearly
  54. Antibody Therapy
  55. Gail Model
  56. HER-2
  57. MRI
  58. 1 in 8 women
  59. Bilateral Prophylactic Mastectomy
  60. Radiotherapy
  61. Mastectomy
  62. Women ages 20-39 yo should have a clinical breast exam at least every 3 years.
  63. Alcohol intake of more than two drinks per day is a risk factor for breast cancer
  64. Estimated 2,150 men will be diagnosed with breast cancer and approximately 410 will die each year
  65. Estradiol
  66. Lumpectomy
  67. Apoptosis
  68. Neoadjuvant Therapy
  69. Lump
  70. Pathologic Response
  71. Lymphoscintigraphy
  72. Chemotherapy
  73. Genetic Predisposition
  74. In-situ Carcinoma
  75. Node Positive
  76. Mammography is a low-dose X-ray examination that can detect breast cancer two years before it is large enough to be felt
  77. Family History
  78. Megestrol Acetate
  79. African-American women have a lower chance of breast cancer overall, but they are 40% more likely to die from breast cancer than white women
  80. Adjuvant Therapy
  81. Gene Mutation
  82. Metastasis
  83. Hormone Replacement Therapy
  84. Tumor Grade
  85. BI-RADS
  86. Triple Positive Breast Cancer
  87. Chemoprevention
  88. Neoplasm
  89. Fibroadenoma
  90. BOCA
  91. Breast Cancer
  92. CAM
  93. Morphea
  94. Absolute Risk
  95. Tamoxifen
  96. Phyllodes Tumor
  97. Breast cancer is the leading cause of death in women between the ages of 40 and 55
  98. RAD
  99. Lymph Node Status
  100. Invasive Breast Cancer
  101. Cyst
  102. mTOR Inhibitors
  103. Germline Mutation
  104. SERM
  105. Precision Medicine
  106. Physical activity may reduce the risk of breast cancers
  107. Biopsy
  108. Adenocarcinoma
  109. Oligometastases
  110. Cachexia
  111. CDK4/6 Inhibitors
  112. Multimodality Therapy
  113. Advocacy
  114. Alopecia
  115. Brachytherapy
  116. Intraductal Papilloma
  117. Cytotoxic
  118. ER-
  119. LCIS
  120. Relapse
  121. Palpation
  122. AC Chemotherapy
  123. CMF Chemotherapy
  124. Kappa Epsilon
  125. Immunotherapy
  126. For every 1,000 screening mammograms performed, about five breast cancers are detected.